Express News | ZyVersa Therapeutics Q3 2024 GAAP EPS $(2.43) Beats $(3.70) Estimate

BenzingaNov 14 08:14 ET

Express News | Zyversa Therapeutics - Qtrly Loss per Share $2.43

ReutersNov 14 08:10 ET

ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

Globe NewswireNov 14 08:10 ET

Press Release: ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

Dow JonesNov 14 08:10 ET

Express News | Zyversa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

ReutersNov 14 08:10 ET

10-Q: Q3 2024 Earnings Report

SECNov 14 08:06 ET · Announcements